期刊文献+

急性淋巴细胞白血病患儿SF及β2-MG检测的临床意义 被引量:2

Clinical Significance of Serum Ferritin and β2-MG Detection in Children with Acute Lymphoblastic Leukemia
原文传递
导出
摘要 目的观察急性淋巴细胞白血病(ALL)患儿血清铁蛋白(SF)及β2-微球蛋白(β2-MG)水平变化,探讨SF和β2-MG水平变化对ALL患儿临床治疗效果的应用价值。方法对2008年7月-2010年4月期间血液病区住院确诊为ALL的患儿53例,病情得到控制缓解后的ALL患儿28例,分别抽取空腹静脉血进行SF和β2-MG测定,并选取正常健康儿童30例作为对照组。结果 ALL患儿治疗前血清SF和β2-MG水平均高于正常对照组(P<0.01),经治疗缓解后ALL患儿的SF和β2-MG水平显著降低,并随着病情的转归而逐渐恢复至正常水平;与治疗前比较,差异有统计学意义(P<0.01)。结论 SF和β2-MG可作为ALL临床治疗效果的有效监测指标。 Objective To observe the dynamic changes of Serum Ferritin( SF) and β2-MG levels in children with acute lymphoblastic leukemia( ALL) and to investigate its clinical significance on clinical curative effect. Methods Fifty-three in-patients with ALL,28 relieved patients from July 2008 to April 2010 in our Hematology and 30 normal as control were selected in our study. The venousblood of patients and controls were extract in order to detect SF and β2-MG. Results Before the treatment,the level of SF and β2-MG in ALL group were significantly higher than those in the control group ( P 〈0. 01). After the treatment,the level of SF and β2-MG in ALL group decreased significantly ( P 〈0. 01) ,and they return to normal level gradually with the outcome; compared with before the treatment,the differences were statistically significant( P 〈0. 01). Conclusion SF and β2-MG can be used as a helpful indicator to evaluate the therapeutic effect of ALL.
出处 《华西医学》 CAS 2010年第8期1513-1514,共2页 West China Medical Journal
关键词 血清铁蛋白 Β2-微球蛋白 急性淋巴细胞白血病 儿童 Serum ferritin β2-Microglobulin Acute lymphoblastic leukemia Children
  • 相关文献

参考文献9

二级参考文献38

共引文献428

同被引文献16

  • 1葛祥花,隋金财,刘景玲,孙桂珍.多发性骨髓瘤血清β_2-MG及LDH检测的临床意义[J].白血病.淋巴瘤,2006,15(2):124-125. 被引量:5
  • 2曹志红,祝焱,彭敏源.急性白血病LDH及HBDH测定的临床意义[J].实用预防医学,2007,14(2):489-490. 被引量:10
  • 3Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classication of myeloid ne- oplasms and acute leukemia: rationale and important changes [ J ]. Blood, 2009,114:937 - 95.
  • 4Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes [ J ]. Blood. 1997,89:2079 -2088.
  • 5Kikuehi S, Kobune hi, Iyama S, et al. Prognostic significance of serum ferritln level at diagnosis in myelodysplastlc syndrome[J]. Int J Hematol,2012, 95 ;527 - 534.
  • 6F Wimazal, W R Sperr, M Kundi, et al. Prognostie signifieanee of serial determinations of lactate dehydrogenase (LDH) in the fol- low-up of patients with myelodysplastic syndromes [ J ]. Ann On- col ,2008,19:970 - 976.
  • 7Friedrich Wimazala, Wolfgang R Sperm, Michael Kundib, et al. Prognostic value of lactate dehydrogenase activity in myelodysplas- tic syndromes[ J]. Leukemia Research,2001, 25:287 -294.
  • 8Simona Gatto, Grog Ball, Franeesco Onida, et al. Contribution of132 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome ( bIDS ) [ J ]. Blood, 2003,102 ( 5 ) : 1622 - 1625.
  • 9武霄云,陈双,赵芳.血清铁蛋白水平在初诊骨髓增生异常综合征的意义[J].中华,临床医师杂志:电子版,2013,7(24):11384-11386.
  • 10Sato T, Kobune M, Murase K, et al. Iron chelator deferasirox res- cued mice from Fasinduced fulminant hepatitis[ J ]. Hepatol Res, 2011,41:660 -667.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部